###### Key messages

What is already known about this subject?
=========================================

-   Patients with heart failure should be referred to cardiac rehabilitation; however, less than 20% of eligible patients access such services.

-   Exercise training and physical activity have been shown to benefit patients, yet too few programmes assess fitness prior to starting rehabilitation.

-   Little is known about which clinical and patient characteristics determine fitness.

What does this study add?
=========================

-   This study is the first to determine the extent by which comorbidities determine walking fitness in patients with a primary diagnosis of heart failure.

How might this impact on clinical practice?
===========================================

-   These findings have led to the development of walking fitness reference values which can be used by clinicians and patients to understand their level of fitness and help set realistic goals as part of their cardiac rehabilitation programme and long-term self-management.

Introduction {#s1}
============

Cardiac rehabilitation (CR) for patients with coronary heart disease and those with heart failure (HF) is a clinically effective intervention that has yet to achieve optimal uptake in routine clinical practice.[@R1] The stated ambition of NHS England is to improve uptake from 45% in 2014 to greater than 65% by 2020 which is an initiative that aligns with the National Institute for Health and Care Excellence guidance recommendations in the UK[@R4] and international guidance.[@R6] Cardiologists and cardiac nurses play a fundamental role in the early treatment and management of heart disease and they represent the primary source of referral to CR.[@R8]

National audit data from the UK[@R3] show that uptake to CR is around 50% for patients with acute coronary syndrome and equivalent to one-third in European and American CR programmes.[@R9] The situation is much worse for patients with HF where uptake is less than 20% of all eligible patients in the UK.[@R3] Referral to CR for patients with HF has yet to become routine practice with most programmes already stretched by the sheer volume of patients attending through the conventional cardiology referral pathways.[@R3]

We hypothesise that one of the reasons so few patients with HF attend CR and many programmes are unable to recruit patients with HF is, in part, due to a perception that 'exercise training and rehabilitation' are at odds with a patient's diagnosis of HF. There is an urgent need to create a more realistic view of what a patient with HF can achieve in terms of physical exercise and fitness. Although clinical trial data on HF exist suggesting what is possible in terms of maximal exercise capacity, obtained from cardiopulmonary exercise testing (CPET), this tends to be based on an exclusive population that are much younger, by as much as 11 years, and have fewer comorbidities[@R1] compared with patients who attend routine practice CR.[@R3]

The incremental shuttle walk test (ISWT) is the most commonly used test of functional physical fitness in the UK.[@R3] Although the ISWT does not represent a 'criterion maximal test', of exercise capacity it is a recommended submaximal surrogate measure of exercise capacity[@R13] that is positively validated against CPET.[@R14] Some studies have used the ISWT to investigate potential determinants of walking fitness in conventional cardiac patients[@R15] identifying age, height, body mass index (BMI) and the presence of diabetes as significant predictors of distanced achieved. The New York Heart Association (NYHA) Functional Classification is an established symptom and function-aligned measure, classifying the extent of HF severity in patients, yet has not been investigated for its role in determining walking fitness as measured by the ISWT in HF.

This study aims to investigate and assess the strength of association between walking fitness and relevant patient demographics, risk factors, comorbidities and severity of HF. Our findings aim to create new knowledge to guide clinical decisions about the characteristics of patients with HF taking part in exercise-based CR.

Methods {#s2}
=======

This study used a robust observational methodology to evaluate the potential contribution of individual patient characteristics in defining physical fitness in patients with HF attending a CR assessment.

Data {#s2-1}
----

The study used data from a routinely collected audit of CR, British Heart Foundation (BHF) and the National Audit of Cardiac Rehabilitation (NACR). The NACR collects data from CR programmes across the UK and has a 74% coverage for electronic data entry.[@R3] The electronic data were acquired in a link-anonymised format from 224 programmes, which collect data on patient's demographics, risk factors and baseline measures prior to starting CR. The data collection of patient information is covered by Section 251 approval which is reviewed by NHS Digital annually, the rationale for data collection was to improve the quality of CR service delivery for public benefit. Patients were included if they had an initiating event (primary diagnosis of HF) between 1 January 2013 and 30 October 2018. To account for potential reporting bias through missing data, the HF population without an ISWT score was compared with the ISWT group in the context of age and gender. A planned subanalysis investigated the extent by which HF severity, defined by the NYHA Functional Classification, determined walking fitness.

The primary variable of interest (dependant variable) is maximum distance walked in metres measured by the ISWT as part of a prerehabilitation assessment. The ISWT is an externally paced (via audio player) and graded walk test with 12 levels of speed that has been validated in cardiac and pulmonary rehabilitation populations.[@R14] Although the test result can be reported by the speed level achieved our planned analysis used distance walked as a continuous variable in the linear regression model which also enabled us to pursue reference values using a measure (metres walked) which are more relevant to clinicians and patients.

Statistical analysis {#s2-2}
--------------------

The analyses were conducted in IBM statistical package SPSS V.25 (SPSS). Correlation and group comparisons used t-tests and Pearson correlation, respectively. Subject to having sufficient data to fulfil statistical distribution assessments (n\>30) all potential covariates were investigated in the analysis. Backwards stepwise linear regression models were built to investigate whether, accounting for covariates, the patient-level factors were associated with walking fitness as measured by ISWT distance.

Relevant important covariates were included in the analysis, where they were evidenced in the literature or significant in preliminary analysis. Age (years), gender (male/female), marital status (single/not) and employment status have been shown to influence the outcomes following a variety of different rehabilitation interventions, including CR. Employment status was coded as employed/retired or unemployed, this is because previous research found that employed and retired states have similar effects on outcomes. Other risk factors such as BMI, physical activity, smoking status, psychosocial well-being measured through Hospital Anxiety Depression Scale (HADS) score and comorbidity were included as they are routinely reported by the NACR as variables that influence patient engagement with CR.[@R3]

Statistical level for significance was p\<0.05 and actual significant values were expressed as reported up to 0.001. Data model checking was performed to ensure that the models were a good fit through assumptions associated with the regressions.

Results {#s3}
=======

This study consisted of 1519 patients (68% male) with HF who had completed an ISWT. The mean age for total population was 64.5 (SD 12.7) years. [Table 1](#T1){ref-type="table"} shows the average ISWT distances in metres for each of the included variables. The overall mean distance was 266.6 m (156.4 SD). Pearson correlation indicates that there is a significant negative relationship between age and ISWT distance of −0.40 (p≤0.001), which was stronger for females (r=−0.436) than males (r=−0.391).

###### 

Incremental shuttle walk test (ISWT) distance for all included variables

  Patient characteristics       ISWT distance (m)                                              
  ----------------------------- ------------------- -------- ------ ------------ ------------- ---------
  Age                           64.51               12.70    1519   −0.40 (PC)   \<0.001       
  Gender                                                                                       
   Male                         284.3               162.65   1035   68           55.71 (MD)    \<0.001
   Female                       228.6               134.94   482    32                         
  Ethnicity                                                                                    
   White                        263.7               151.47   1136   75           −11.74 (MD)   0.204
   Non-white                    275.4               170.15   383    25                         
  Smoking Status                                                                               
   No                           266.5               153.31   1304   93           −10.61 (MD)   0.503
   Yes                          277.1               179.31   104    7                          
  Physical activity status                                                                     
   No                           246.5               153.92   887    68           −60.85 (MD)   \<0.001
   Yes                          307.4               149.56   408    32                         
  Body mass index (BMI)                                                                        
   \<30                         276.2               163.18   827    59           25.42 (MD)    0.002
   \>30                         250.8               138.64   586    41                         
  Employment status                                                                            
   Employed                     262.5               152.63   995    79           −9.53 (MD)    0.366
   Unemployed                   272.1               156.78   266    21                         
  Marital status                                                                               
   Single                       246.9               157.08   359    31           −19.36 (MD)   0.039
   Partner                      266.2               143.44   799    69                         
  HADS score: Anxiety                                                                          
   Not anxious                  271.6               155.81   1042   83           36.79 (MD)    0.002
   Anxious                      234.8               145.82   209    17                         
  HADS score: Depression                                                                       
   Not depressed                274.2               154.71   1082   86           64.78 (MD)    \<0.001
   Depressed                    209.4               143.38   169    14                         
  IMD score                                                                                    
   Lowest quintile              265.5               173.68   263    22.1         0.43 (F)      0.789
   Second quintile              256.6               163.18   277    23.3                       
   Third quintile               259.6               144.28   221    18.6                       
   Fourth quintile              267.9               157.85   232    19.5                       
   Fifth quintile               274.3               161.18   196    16.5                       
  Total population ISWT score   266.6               156.41                                     

ANOVA, analysis of variance; HADS, Hospital Anxiety Depression Scale; IMD, Index of Multiple Deprivation; MD, mean difference; PC, pearson correlation.

In absolute terms males had a significantly larger ISWT distance on average 55.7 m greater than females (p≤0.001). Patients with a history of achieving moderate physically active status had on average a statistically significant 60.9 m greater distance than those who were not (p≤0.001). Patients with BMI greater than 30 demonstrated shorter ISWT distances by on average 25.4 m (p=0.002). Marital status of patients was significantly associated with walking fitness, those with a partner had 19.4 m greater than those single (p=0.039). No other variables were associated with differences in ISWT distance. Patients who were either anxious or depressed at baseline, HADS score ≥8, had significantly lower walking distances than those patients with HADS score below 8 (p\<0.05).

Additionally, the study included as subset analysis the inclusion of NYHA class I--IV, the analysis failed to find any significant differences between the NYHA class and ISWT distance (p\>0.05).

[Table 2](#T2){ref-type="table"} shows the ISWT distance, when analysed against the patient's comorbidity status. Eighteen comorbidities captured on the NACR were included, along with a single-variable coding multimorbidity of ≤3 or 3+. The results showed that patients having angina, arthritis, diabetes, stroke, hypertension, chronic obstructive pulmonary disease (COPD), asthma and chronic back problems demonstrated significantly lower ISWT distance (mean difference range 28.2--55.3, p\<0.05).

###### 

Incremental shuttle walk test (ISWT) distance reported by comorbidity category

                                          ISWT distance (m)                               
  --------------------------------------- ------------------- ------- ------ ---- ------- ---------
  Angina                                                                                  
   No                                     270.0               158.5   1419   93   51.6    0.001
   Yes                                    218.5               114.1   110    7            
  Arthritis                                                                               
   No                                     276.3               158.3   1262   83   57.1    \<0.001
   Yes                                    219.2               137.5   257    17           
  Cancer                                                                                  
   No                                     268.6               158.7   1383   91   22.0    0.117
   Yes                                    246.6               130.2   136    9            
  Diabetes                                                                                
   No                                     276.7               161.1   1207   79   48.8    \<0.001
   Yes                                    227.9               129.9   312    21           
  Stroke                                                                                  
   No                                     270.0               158.0   1424   94   53.1    0.001
   Yes                                    216.9               120.6   95     6%           
  Hypertension                                                                            
   No                                     276.6               164.1   982    65   28.2    0.001
   Yes                                    248.4               139.6   537    35           
  Chronic obstructive pulmonary disease                                                   
   No                                     270.6               157.8   1409   93   55.3    0.001
   Yes                                    215.4               126.9   110    7            
  Asthma                                                                                  
   No                                     269.2               157.8   1394   92   31.4    0.031
   Yes                                    237.8               137.1   125    8            
  Chronic back problems                                                                   
   No                                     272.0               158.5   1306   86   38.1    0.001
   Yes                                    233.8               138.7   213    14           
  Anxiety                                                                                 
   No                                     265.8               156.0   1402   92   −11.4   0.449
   Yes                                    277.2               161.9   117    8            
  Depression                                                                              
   No                                     268.3               158.8   1372   90   16.8    0.217
   Yes                                    251.5               131.4   147    10           
  Family history                                                                          
   No                                     266.0               159.1   1253   82   −3.5    0.741
   Yes                                    269.5               143.1   266    18           
  Erectile dysfunction                                                                    
   No                                     267.3               157.4   1436   95   12.9    0.466
   Yes                                    254.5               138.5   83     5            
  Hypercholesterolaemia/dislipidaemia                                                     
   No                                     269.0               159.0   1280   84   15.3    0.166
   Yes                                    253.8               141.7   239    16           
  Comorbidities grouped                                                                   
   ≤3                                     282.0               166.0   967    64   42.2    \<0.001
   \>3                                    239.8               134.1   552    36           

Osteoporosis, claudication and rheumatism were removed due to insufficient subset sample sizes (n≤25).

The number of comorbidities was also significant with a 42.19 m reduced mean difference with having more than three comorbidities.

[Table 3](#T3){ref-type="table"} shows the results from the linear regression evaluating the association between ISWT distance against patient characteristics and related risk factors. The model confirms that age, after accounting for multiple potential confounders, was negatively associated ISWT distance (B=−4.868, p\<0.001). The effect of age is centralised around the mean suggesting that for each single-year increase in age, above the mean, there is an associated 5.5 m reduction in distance walked.

###### 

Linear regression findings for the incremental shuttle walk test (ISWT) by patient characteristics

  Patient characteristics                   B         SE       t         Significance   95% CI
  ----------------------------------------- --------- -------- --------- -------------- --------------------
  Gender (Female)                           −42.123   10.658   −3.952    \<0.001        −63.055 to −21.191
  Age                                       −4.868    0.447    −10.888   \<0.001        −5.746 to −3.990
  Ethnicity (Non-white)                     −23.347   13.340   −1.750    0.081          −49.545 to 2.852
  Physical activity status (150 min/week)   43.467    10.543   4.123     \<0.001        22.761 to 64.173
  BMI (\>30)                                −28.645   10.203   −2.808    0.005          −48.682 to −8.607
  Employment status (Unemployed)            −50.336   12.951   −3.887    \<0.001        −75.771 to −24.901
  Diabetes                                  −33.448   12.318   −2.715    0.007          −57.639 to −9.257
  Chronic back problems (Yes)               −36.855   13.392   −2.752    0.006          −63.155 to −10.554
  COPD (Yes)                                −39.310   18.937   −2.076    0.038          −76.501 to −2.119
  HADS score: Depression (Depressed)        −52.194   14.842   −3.517    \<0.001        −81.342 to −23.045
  IMD score                                 11.624    3.801    3.058     0.002          4.160 to 19.088
  Intercept                                 276.703   13.339   20.744    \<0.001        250.506 to 302.899

R=0.530. R^2^=0.281. Adj R^2^=0.266.

BMI, body mass index; COPD, chronic obstructive pulmonary disease; HADS, Hospital Anxiety Depression Scale; IMD, Index of Multiple Deprivation.

Gender plays a significant part in determining walking fitness with female patients having a 42 m reduced walking distance (p\<0.001). Other covariates of statistical significance associated were ethnicity, employment status, marital status, physical activity, BMI and socioeconomic class. Patients being unemployed, with greater BMI and not achieving physical activity status were all associated with a lower ISWT score between 29 and 50 m (p=0.05--0.001). For every increase in socioeconomic class quintile the patient's baseline ISWT increased by 8.5 m, thus being from the lowest as opposed to the highest quintiles was a difference of 44 m (p=0.002). Patients being identified as clinically or borderline depressed at baseline using the HADS score performed on average 52 m worse than those who were classified as normal (p\<0.001).

Variables that were not significant such as smoking status, other covariates and multimorbidity were automatically removed from the backward stepwise analysis.

The model was of good fit and the residuals met the assumptions of uniform variance and linearity, and the adjusted r^2^ value was 0.266. The grouping of comorbidities into less than or greater than 3 was not significantly associated with walking fitness. Subset analysis showed that the model with NYHA was not of greater fit. The inclusion of NYHA class was not statistically significant.

[Table 4](#T4){ref-type="table"} presents our proposed reference values for ISWT distance split by age, gender and COPD set within 5, 25, 75 and 95 percentiles.

###### 

Incremental shuttle walk test reference values for patients with heart failure (HF) split by age, gender and presence of chronic obstructive pulmonary disease (COPD) and depression

  Heart failure (HF)+comorbidity category   Age and gender   Incremental shuttle walk test (ISWT)   Count                           
  ----------------------------------------- ---------------- -------------------------------------- ------- ----- ----- ----- ----- ----
  HF only                                   \<67 years                                                                              
  Male                                      338              180                                    70      200   460   630   443   
  Female                                    285              145                                    70      190   350   520   190   
  67+ years                                                                                                                         
  Male                                      243              138                                    60      140   330   480   434   
  Female                                    184              109                                    40      100   250   390   211   
  HF+COPD                                   \<67 years       237                                    133     40    120   330   430   51
  67+ years                                 197              120                                    40      90    270   470   59    
  HF+Depression                             \<67 years       261                                    143     30    150   340   520   95
  67+ years                                 223              107                                    70      155   295   420   52    

Discussion {#s4}
==========

Reassuringly our findings showed that patients with a primary diagnosis of HF, referred to CR, were capable of levels of walking fitness, achieved through challenging incremental test, comparable to the 25th--50th centiles of patients with conventional cardiovascular disease attending CR.[@R17] Although the extent of walking fitness was greater by 42 m in the group with fewer comorbidities (≤3), a good mean distance of 240 m was achieved in the group having greater than three additional comorbidities. These findings help establish a positive picture in terms of physical fitness for those patients with the diagnosis of HF and willingness to engage in rehabilitation.

Using mean age of the study population (64.5±12.7) as a reference value, being older by 1 year was significantly associated with reduced walking distances in the region of 4.9 m for each year above mean age. This relationship is not new as it is evident in the conventional CR patient populations[@R16]; however, the ability to quantify the extent of loss, with increasing age, represents a novel finding in patients with HF.

After accounting for comorbidities gender continues to play a significant part in determining walking fitness with female patients having a 42 m reduced walking distance. The CR literature and routine practice data, captured in national reports,[@R3] highlight that around 80% of patients with HF are missing out on CR and of those who do attend around one-third have a recorded physical fitness assessment.[@R3] National clinical guidance worldwide recommends assessment of physical fitness prior to starting CR[@R6] yet two-thirds of patients in the UK are not assessed. In terms of HF the lack of physical assessment may not purely be the fault of programmes and could, in part, be explained by the incapacity of patients or in some cases a perceived incapacity to carry out a walk test especially an incremental test. Our research has produced reference values to help clarify physical fitness expectations for patients with HF attending CR and for clinicians to aid goal setting at the start of CR ([table 4](#T4){ref-type="table"}).

A knowledge of age and gender differences in walking fitness aligned with fitness determining comorbidities such as COPD and depression, as shown in [table 4](#T4){ref-type="table"}, is considered useful in clarifying HF-specific physical fitness expectations for CR programme staff, patients and carers.

The presence of COPD in the form of chronic bronchitis or emphysema is significant in predicting fitness in patients with HF resulting in a 39 m reduction walking distance. COPD is dominated by the symptom of breathlessness, at rest, and exacerbated by physical effort which on top of the diagnosis of HF possibly explains such lower levels of fitness.[@R18] The severity of HF as measured by NYHA did not reach significance as a determinant which might be explained by the analysis accounting for COPD. Within the NYHA class groups the proportion with COPD was 4% for class 1, 5% for class 2, 11% for class 3% and 31% for class 4. The inter-relation between HF and COPD is becoming increasingly important clinically leading to a call for a service provision aimed at managing breathlessness in patients with these comorbidities.[@R18]

A new finding for patients with HF was that higher levels of depression, measured using HADS, were strongly associated with poorer walking fitness. This has not been investigated previously in HF; however, our findings concur with a robust systematic review in healthy and depressed adult populations where depression and physical fitness were found to be inversely correlated.[@R19]

[Table 4](#T4){ref-type="table"} incorporates the impact of COPD and depression on walking fitness reference values for younger and older patients with the combination of HF+COPD or HF+depression. This is the first set of reference values to account for the presence of such variables alongside HF which should enable clinicians to better understand physical fitness differences and/or expectations of their patients.

Our findings have generated new knowledge to help guide clinical decisions about the suitability of patients with HF to take part in exercise-based CR. The study also produced a set of reference values aligned with age, gender, COPD and depression to aid the interpretation of walking fitness in patients with HF in the hope that this new knowledge will help improve referral and uptake to CR.

Limitations {#s4-1}
-----------

Although the study investigated a large number of covariates, we were unable to account for medications such as diuretics and beta-blockers that may have accounted for some variation within the population in terms of weight gain and walking fitness, respectively.

Concerning our subanalysis of HF severity using NYHA there was a potential reporting bias through missing data. Although we cannot rule this out our analysis of the population with and without a recorded NYHA classification showed no significant differences for age and gender.

The mean age of patients recruited was 64.5 (SD 12.7) years which is below that seen in the general HF population. Our approach to ISWT reference values utilises the median distribution above and below 67 years which better reflects the full range of patients.

Conclusion {#s5}
==========

The study concludes that patient age, gender, ethnicity, physical activity and depression status, along with the presence of COPD as comorbidity, were significant factors in predicting walking fitness in patients with HF. This is the first study to clarify the extent by which patient characteristics determine walking fitness in patients with HF and these findings have the potential to aid clinician understanding of the levels of fitness patients with HF can achieve. The study produced a novel set of reference values, aligned with age, gender, COPD and depression, to aid the interpretation of walking fitness by clinicians and patients. Through dissemination of these findings we believe this knowledge has potential to improve confidence in clinicians making a referral to CR and lead to a greater number of patients undergoing a physical fitness assessment thus enabling an appropriate exercise prescription.
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